Literature DB >> 10194941

["Targeted delivery" in the gastrointestinal tract].

C S Leopold1.   

Abstract

Drug delivery to the intestine has become attractive to researchers with the main interest in the delivery of peptide drugs to the large intestine and the treatment of colonic diseases. There are currently 4 strategies that are pursued to reach colon specificity: 1. by relying on the pH difference between the small and the large intestine; 2. by exploiting the enzymatic activity of the colonic microflora; 3. by relying on the relatively constant small intestinal transit time and 4. by taking advantage of the increase of the luminal pressure in the colon due to strong peristaltic waves. Drug delivery to the small intestine may be achieved by pH-controlled and time-controlled drug release mechanisms. Diffusion-controlled systems allow drug delivery over the entire gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194941     DOI: 10.1007/bf03042026

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  33 in total

1.  Colonic drug delivery: enhanced release of indomethacin from cross-linked chondroitin matrix in rat cecal content.

Authors:  A Rubinstein; D Nakar; A Sintov
Journal:  Pharm Res       Date:  1992-02       Impact factor: 4.200

2.  Crosslinked dextran--a new capsule material for colon targeting of drugs.

Authors:  H Brøndsted; C Andersen; L Hovgaard
Journal:  J Control Release       Date:  1998-04-30       Impact factor: 9.776

3.  Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD).

Authors:  C S Leopold; D Eikeler
Journal:  J Drug Target       Date:  1998       Impact factor: 5.121

4.  Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon.

Authors:  H Tozaki; J Komoike; C Tada; T Maruyama; A Terabe; T Suzuki; A Yamamoto; S Muranishi
Journal:  J Pharm Sci       Date:  1997-09       Impact factor: 3.534

5.  Measurement of gastrointestinal pH profiles in normal ambulant human subjects.

Authors:  D F Evans; G Pye; R Bramley; A G Clark; T J Dyson; J D Hardcastle
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

6.  Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis.

Authors:  M J Dew; R E Ryder; N Evans; B K Evans; J Rhodes
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

7.  Bioavailability of ketoprofen from orally administered ketoprofen-dextran ester prodrugs in the pig.

Authors:  C Larsen; B H Jensen; H P Olesen
Journal:  Acta Pharm Nord       Date:  1991

8.  In-vitro evaluation of biphenylyl acetic acid-beta-cyclodextrin conjugates as colon-targeting prodrugs: drug release behaviour in rat biological media.

Authors:  F Hirayama; K Minami; K Uekama
Journal:  J Pharm Pharmacol       Date:  1996-01       Impact factor: 3.765

9.  Development of a colonic release capsule dosage form and the absorption of insulin.

Authors:  M E Kraeling; W A Ritschel
Journal:  Methods Find Exp Clin Pharmacol       Date:  1992-04

10.  Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs.

Authors:  K Niwa; T Takaya; T Morimoto; K Takada
Journal:  J Drug Target       Date:  1995       Impact factor: 5.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.